VLCKD: a real time safety study in obesity

Area of Science:

• Nutrition Science
• Metabolic Health
• Obesity Management

Background:

• Very Low-Calorie Ketogenic Diet (VLCKD) shows promise for obesity treatment.
• Limited data exists on VLCKD side effects in obese populations.
• Previous studies often involved non-obese individuals for different therapeutic goals.

Purpose of the Study:

• To evaluate the safety of VLCKD in individuals with obesity.
• To determine if VLCKD-induced side effects affect its effectiveness for weight loss.
• To assess the clinical and biochemical parameters associated with VLCKD in obese subjects.

Main Methods:

• Prospective study enrolling 106 obese subjects (BMI 34.98 ± 5.43 kg/m²).
• Recorded side effects and assessed anthropometric parameters pre- and post-VLCKD.
• Evaluated biochemical parameters in a subgroup of 25 participants.

Main Results:

• No serious adverse events were reported; observed side effects were mild and manageable.
• Only 8.5% discontinued VLCKD due to palatability or cost, not side effects.
• Weight loss percentage did not differ significantly between subjects with and without side effects (13.5% vs 18.2%).

Conclusions:

• VLCKD is a safe and effective therapeutic option for obesity management.
• Mild and transient side effects can be prevented and managed with proper protocols.
• Adherence to indications, contraindications, and monitoring ensures VLCKD efficacy and safety.